Interest of Real Time Measurement of Autonomous Nervous System for the Detection of Brain Death
NCT ID: NCT00918970
Last Updated: 2009-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
30 participants
OBSERVATIONAL
2008-08-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The diagnosis of brain death is strictly defined by the law and relies either on two consecutive flat electroencephalograms recorded at an interval of four hours, or on the lack of cerebral circulation during a brain angiography performed after suspecting brain death on the clinical exam. However, in usual practice, it is difficult to have all the needed clinical arguments, and their interpretation can be difficult in the pathological context. This may participate in the delay and the lack of patients potentially donors.
Pre-study: In a pilot study, fifty subjects with severe cerebral lesions, had a continuous ECG recording. The investigators could find that a decrease in autonomic nervous system activity, as measured through the ECG, was correlated to the transition to brain death assessed by cerebral angiography. The loss of cardiac variability was always observed between two cerebral angiographies, one before and the second after brain death. This study allowed the investigators to calculate the threshold values of sympathetic and parasympathetic activities to confirm brain death.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Severe Brain Injury on Neuro-vascular and Endothelial Regulation of Peripheral Microcirculation.
NCT04597879
Metabolic Imaging of Neurological Disease
NCT06900244
Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury
NCT04854954
Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases
NCT04700748
The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography
NCT00256802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Benefits expected: Increase the number of organ donors and the number of organs removal available for transplantation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SNA group
This group will have a real-time analysis of autonomic nervous system activity during its intensive care hospitalisation
No interventions assigned to this group
Clinical group
This group will have a conventional clinical analysis during its intensive care hospitalisation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted in intensive care units
Exclusion Criteria
* prior myocardiac infarction
* hearth failure
* atrial fibrillation
* insulin-treated diabetes mellitus
* cardiac pacemaker
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CHU de SAINT-ETIENNE
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David CHARIER, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint-Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Dijon
Dijon, , France
CH Roanne
Roanne, , France
CHU de Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CNIL 908.476
Identifier Type: -
Identifier Source: secondary_id
0708045
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.